Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shiwei Qingyang Decoction
- Development stage
- Unknown
- Lead developer
- Shuguang Hospital
- Administration
- Oral
01
Overview
Shiwei Qingyang Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by Shuguang Hospital, affiliated with the Shanghai University of Traditional Chinese Medicine. It was specifically designed for the treatment of COVID-19 infections, particularly those caused by the Omicron variant. As a "Shiwei" (ten-ingredient) decoction, it consists of a specific combination of ten medicinal herbs intended to alleviate clinical symptoms such as fever, cough, and fatigue. The formula is used to clear heat and detoxify the body according to TCM principles and was evaluated in clinical trials during the pandemic response in Shanghai.
- Other names
- Shiwei Qingyang Formula十味卿阳方
Beyond the preview
Go deeper on Shiwei Qingyang Decoction.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shiwei Qingyang Decoction.